Skip to main content
iNtRON Biotechnology, Inc. logo

iNtRON Biotechnology, Inc. — Investor Relations & Filings

Ticker · 048530 ISIN · KR7048530000 KO Manufacturing
Open in API
Filings indexed 268 across all filing types
Latest filing 2019-01-16 Director's Dealing
Country KR South Korea
Listing KO 048530

About iNtRON Biotechnology, Inc.

https://intronbio.com:6001

iNtRON Biotechnology, Inc. is a biotechnology company specializing in solutions for infectious diseases. Its core activities are centered on three main pillars: bio-new drugs, molecular diagnostics, and molecular biology reagents. The company's therapeutic pipeline focuses on developing novel treatments for drug-resistant super-bacteria, creating antibiotic alternatives and other bio-active agents to address the challenge of antimicrobial resistance (AMR). In its diagnostics division, iNtRON develops and manufactures detection kits and assays, primarily based on real-time PCR technology, for the rapid identification of infectious organisms. The company also provides a range of molecular reagents for research and has commercialized antibiotic alternative products for the animal health market.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and the Korea Exchange. This type of filing is a standard regulatory requirement for insiders (directors/executives) to disclose their shareholdings and any changes therein. Based on the provided categories, this falls under 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2019-01-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used by executives and major shareholders to report changes in their shareholdings, which falls under the category of 'Director's Dealing' (DIRS) in the provided classification schema.
2019-01-16 Korean
권리락(무상증자)
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement regarding a 'rights off' (ex-rights) event due to a bonus issue (free share issuance) for Intron Biotechnology. It provides specific details like the reference price and the effective date. Since it announces a capital change event (bonus issue) rather than being a full report, and specifically details the share-related adjustment, it falls under the category of share issue/capital change announcements.
2019-01-09 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the National Pension Service's change in shareholding percentage in Intron Biotechnology. This falls under the category of Major Shareholding Notification (MRQ).
2019-01-04 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company (Intron Biotechnology) regarding a 'Free Capital Increase' (무상증자결정). In the context of Korean corporate filings (DART system), this type of report detailing capital structure changes, such as bonus issues or stock splits, falls under the category of share issuance and capital changes.
2018-12-18 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change Classification · 95% confidence The document is a short regulatory notice regarding the suspension of stock trading ('주권매매거래정지') for Intron Biotechnology due to a bonus issue ('무상증자'). It cites specific KOSDAQ market regulations. Since it is a brief regulatory announcement regarding trading status and does not fit into specific categories like M&A or dividend announcements, it falls under the general regulatory filing category.
2018-12-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.